Imunon, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Imunon, Inc. (IMNN) had Lessee, Operating Lease, Liability, to be Paid, Year One of $498.09 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-11
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $498.09K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $498.09K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $488.82K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $488.82K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $498.09K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $498.09K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $488.82K 10-K · filed 2026-03-31 |
| 2025-09-30 | $488.82K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $488.82K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $362.98K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $543.01K 10-K · filed 2025-02-27 |
| 2024-09-30 | $543.01K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $543.01K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $543.01K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $626.32K 10-K · filed 2024-03-28 |
| 2023-09-30 | $626.32K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $348.88K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $348.88K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $238.61K 10-K · filed 2023-03-30 |
| 2022-09-30 | $238.61K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $238.61K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $451.92K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $601.50K 10-K · filed 2022-03-31 |
| 2021-09-30 | $149.57K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $266.19K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $398.87K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $530.73K 10-K · filed 2021-03-19 |
| 2020-09-30 | $530.73K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $530.73K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $530.73K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $525.81K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |